Apr 4 |
Why You Shouldn't Bet Against Vor Biopharma (VOR) Stock
|
Mar 29 |
Here's Why We're Watching Vor Biopharma's (NASDAQ:VOR) Cash Burn Situation
|
Mar 20 |
Vor Biopharma GAAP EPS of -$0.39 beats by $0.11
|
Mar 20 |
Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company Update
|
Mar 4 |
Vor Bio to Participate in Upcoming Investor Conferences
|
Feb 17 |
Institutions own 36% of Vor Biopharma Inc. (NASDAQ:VOR) shares but private equity firms control 43% of the company
|
Feb 15 |
2 “Strong Buy” Penny Stocks That Could Rally All the Way to $10 (or More)
|
Feb 7 |
Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
|
Jan 19 |
Vor Bio (VOR) Up on Positive Update From AML Cell Therapy Study
|
Jan 17 |
Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate Update
|